Scientific paper - Review paper
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Current Hematologic Malignancy Reports, 17 (2022), 5; 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, Ivan; Lucijanić, Marko; Verstovšek, Srđan

Cite this document

Krečak, I., Lucijanić, M. & Verstovšek, S. (2022). Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current Hematologic Malignancy Reports, 17. (5), 155-169. doi: 10.1007/s11899-022-00670-8

Krečak, Ivan, et al. "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia." Current Hematologic Malignancy Reports, vol. 17, no. 5, 2022, pp. 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, Ivan, Marko Lucijanić and Srđan Verstovšek. "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia." Current Hematologic Malignancy Reports 17, no. 5 (2022): 155-169. https://doi.org/10.1007/s11899-022-00670-8

Krečak, I., Lucijanić, M. and Verstovšek, S. (2022) 'Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia', Current Hematologic Malignancy Reports, 17(5), pp. 155-169. doi: 10.1007/s11899-022-00670-8

Krečak I, Lucijanić M, Verstovšek S. Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current Hematologic Malignancy Reports [Internet]. 2022 August 06 [cited 2024 September 30];17(5):155-169. doi: 10.1007/s11899-022-00670-8

I. Krečak, M. Lucijanić and S. Verstovšek, "Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia", Current Hematologic Malignancy Reports, vol. 17, no. 5, pp. 155-169, August 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:950177. [Accessed: 30 September 2024]

Please login to the repository to save this object to your list.